NO843956L - Fremgangsmaate for fremstilling av karboksyalkenamido-cefalosporiner - Google Patents

Fremgangsmaate for fremstilling av karboksyalkenamido-cefalosporiner

Info

Publication number: NO843956L
Authority: NO; Norway
Prior art keywords: carboxyalkenamido; cephalosporines; procedure; preparation
Prior art date: 1983-10-04

Application number

NO843956A

Other languages

English (en)

Other versions

NO173238B (no

NO173238C (no

Inventor

Yoshio Hamashima

Original Assignee

Shionogi & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-10-04

Filing date

1984-10-02

Publication date

1985-04-09

1983-10-04 Priority claimed from JP58186601A external-priority patent/JPS6078987A/ja

1984-02-03 Priority claimed from JP59018563A external-priority patent/JPS60163884A/ja

1984-05-18 Priority claimed from JP59100890A external-priority patent/JPH0780892B2/ja

1984-10-02 Application filed by Shionogi & Co filed Critical Shionogi & Co

1985-04-09 Publication of NO843956L publication Critical patent/NO843956L/no

1985-09-27 Priority to NO853806A priority Critical patent/NO176567C/no

1993-08-09 Publication of NO173238B publication Critical patent/NO173238B/no

1993-11-17 Publication of NO173238C publication Critical patent/NO173238C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65613—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Life Sciences & Earth Sciences (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Health & Medical Sciences (AREA)
Cephalosporin Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Photoreceptors In Electrophotography (AREA)
Steroid Compounds (AREA)

NO843956A 1983-10-04 1984-10-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-beta-(karboksyalkenoylamino)-3-cefem-4-karboksylsyre-forbindelser NO173238C (no)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
NO853806A NO176567C (no)	1983-10-04	1985-09-27	Karboksyalkensyrer

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP58186601A JPS6078987A (ja)	1983-10-04	1983-10-04	アクリルアミドセフアロスポリン類
JP59018563A JPS60163884A (ja)	1984-02-03	1984-02-03	カルボキシアルケンアミドセフアロスポリン
JP59100890A JPH0780892B2 (ja)	1984-05-18	1984-05-18	カルボキシアルケンアミドセフアロスポリン

Publications (3)

Publication Number	Publication Date
NO843956L true NO843956L (no)	1985-04-09
NO173238B NO173238B (no)	1993-08-09
NO173238C NO173238C (no)	1993-11-17

Family

ID=27282263

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO843956A NO173238C (no)	1983-10-04	1984-10-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-beta-(karboksyalkenoylamino)-3-cefem-4-karboksylsyre-forbindelser
NO853806A NO176567C (no)	1983-10-04	1985-09-27	Karboksyalkensyrer

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO853806A NO176567C (no)	1983-10-04	1985-09-27	Karboksyalkensyrer

Country Status (22)

Country	Link
US (3)	US4634697A (no)
EP (1)	EP0136721B1 (no)
KR (2)	KR880002376B1 (no)
AR (1)	AR242392A1 (no)
AT (1)	ATE99311T1 (no)
AU (2)	AU575854B2 (no)
CA (2)	CA1238910A (no)
DE (2)	DE3486259T2 (no)
DK (1)	DK171043B1 (no)
ES (3)	ES8604602A1 (no)
FI (1)	FI82057C (no)
GB (3)	GB2154580B (no)
GR (1)	GR80544B (no)
HU (1)	HU193298B (no)
IE (1)	IE57744B1 (no)
IL (3)	IL84653A (no)
MX (1)	MX174328B (no)
NL (1)	NL940013I2 (no)
NO (2)	NO173238C (no)
NZ (2)	NZ209634A (no)
PH (2)	PH20223A (no)
PT (1)	PT79287A (no)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU575854B2 (en) *	1983-10-04	1988-08-11	Shionogi & Co., Ltd.	7beta-(carboxyalkenamido) cephalosporins
JP2501785B2 (ja) *	1984-07-09	1996-05-29	明治製菓株式会社	新規セフアロスポリン系化合物
JPS6124580A (ja) *	1984-07-12	1986-02-03	Shionogi & Co Ltd	アミノチアゾリルグルタル酸誘導体の製造方法
JPS6153272A (ja) *	1984-08-24	1986-03-17	Shionogi & Co Ltd	グルタル酸誘導体の製法
AU580855B2 (en) *	1985-03-29	1989-02-02	Shionogi & Co., Ltd.	Alkeneamidocephalosporin esters
ZA863170B (en)	1985-04-30	1987-12-30	Lilly Co Eli	7-substituted bicyclic pyrazolidinones
US4731362A (en) *	1985-08-05	1988-03-15	Shionogi & Co., Ltd.	Alkylcarbamoyloxymethylcephem compounds
DE3745094B4 (de) *	1986-07-02	2004-12-30	Shionogi & Co., Ltd.	Ein kristallines Hydrat der 7ß-[(Z)-2-(2-Aminothiazol-4-yl)-4-carboxybut-2-enoylamino]-3-cephem-4-carbonsäure enthaltende Hartgelatinekapsel-Zusammensetzung
NZ220764A (en) *	1986-07-02	1989-09-27	Shionogi & Co	Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions
AT396652B (de) *	1986-07-02	1993-11-25	Shionogi & Co	Verfahren zur herstellung von hartgelatinekapsel-zusammensetzungen
US5017380A (en) *	1986-07-02	1991-05-21	Shionogi & Co., Ltd.	Gelatin hard capsule containing crystalline hydrate of oral cephalosporin
US5147871A (en) *	1986-07-03	1992-09-15	Hoffmann La-Roche, Inc.	Anti-bacterial cephalosporin compounds
US5242913A (en) *	1987-03-11	1993-09-07	Pfizer Inc.	Substituted 3-cephem compounds as antibacterial agents
WO1993013108A1 (en) *	1987-03-11	1993-07-08	Susumu Nakanishi	Substituted 3-cephem compounds as antibacterial agents
US4820832A (en) *	1988-03-23	1989-04-11	Eli Lilly And Company	Process for preparing 3-unsubstituted cephalosporins and 1-carba(dethia)cephalosporins
US5336768A (en) *	1988-05-24	1994-08-09	Hoffmann-La Roche Inc.	Antibacterial cephalosporin compounds
CS273349B2 (en) *	1988-03-31	1991-03-12	Hoffmann La Roche	Method of cephalosporin's new derivatives production
US5245027A (en) *	1989-11-21	1993-09-14	Bristol-Myers Squibb Company	3-fluorosulfonyloxyceph-3-em compounds
US5612048A (en) *	1994-11-22	1997-03-18	Amvac Chemical Corporation	Stabilized moisture-sensitive pesticide composition and method of making
US5571910A (en) *	1994-12-09	1996-11-05	Schering Corporation	Process for the preparation of intermediates useful in the synthesis of cephalosporins
JPH101482A (ja) *	1996-06-13	1998-01-06	Otsuka Chem Co Ltd	３−ノルセフェム化合物の製造法
US6544555B2 (en)	2000-02-24	2003-04-08	Advancis Pharmaceutical Corp.	Antibiotic product, use and formulation thereof
US6565882B2 (en) *	2000-02-24	2003-05-20	Advancis Pharmaceutical Corp	Antibiotic composition with inhibitor
US20020068078A1 (en) *	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof
US6541014B2 (en) *	2000-10-13	2003-04-01	Advancis Pharmaceutical Corp.	Antiviral product, use and formulation thereof
US20020197314A1 (en) *	2001-02-23	2002-12-26	Rudnic Edward M.	Anti-fungal composition
US8225458B1 (en)	2001-07-13	2012-07-24	Hoffberg Steven M	Intelligent door restraint
JP4625637B2 (ja)	2002-02-22	2011-02-02	シャイアエルエルシー	活性物質送達系及び活性物質を保護し投与する方法
US20050152852A1 (en) *	2002-05-27	2005-07-14	Morinaga & Co., Ltd.	Use of antibacterial component extracted from cacao mass for inhibiting the growth of periodontal bacteria
WO2005009364A2 (en) *	2003-07-21	2005-02-03	Advancis Pharmaceutical Corporation	Antibiotic product, use and formulation thereof
CA2533178C (en) *	2003-07-21	2014-03-11	Advancis Pharmaceutical Corporation	Antibiotic product, use and formulation thereof
JP2006528190A (ja) *	2003-07-21	2006-12-14	アドバンシスファーマスーティカルコーポレイション	抗生物質製剤、その使用法及び作成方法
US8758820B2 (en) *	2003-08-11	2014-06-24	Shionogi Inc.	Robust pellet
US8062672B2 (en) *	2003-08-12	2011-11-22	Shionogi Inc.	Antibiotic product, use and formulation thereof
CA2535780A1 (en) *	2003-08-29	2005-03-17	Advancis Pharmaceuticals Corporation	Antibiotic product, use and formulation thereof
US8460710B2 (en) *	2003-09-15	2013-06-11	Shionogi, Inc.	Antibiotic product, use and formulation thereof
JP2007517039A (ja) *	2003-12-24	2007-06-28	アドバンシスファーマスーティカルコーポレイション	変性放出製剤の吸収増強
WO2006014427A1 (en) *	2004-07-02	2006-02-09	Advancis Pharmaceutical Corporation	Tablet for pulsed delivery
US20110104109A1 (en) *	2005-07-13	2011-05-05	Frank Bennett	Tetracyclic indole derivatives and their use for treating or preventing viral infections
US8778924B2 (en) *	2006-12-04	2014-07-15	Shionogi Inc.	Modified release amoxicillin products
US8357394B2 (en)	2005-12-08	2013-01-22	Shionogi Inc.	Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) *	2006-05-05	2012-10-30	Shionogi Inc.	Pharmaceutical compositions and methods for improved bacterial eradication
ATE543808T1 (de)	2006-12-22	2012-02-15	Schering Corp	5,6-ring-annelierte indolderivate und ihre verwendung
CN101631773A (zh)	2006-12-22	2010-01-20	先灵公司	治疗或预防hcv和相关病毒感染的4,5-环化吲哚衍生物
US8546420B2 (en) *	2006-12-22	2013-10-01	Merck Sharp & Dohme Corp.	4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
BRPI0816116A2 (pt) *	2007-08-29	2015-03-03	Schering Corp	Derivados de indol 2,3-substituídos para o tratamento de infecções virais.
AR068106A1 (es)	2007-08-29	2009-11-04	Schering Corp	Derivados de indol 2-carboxi sustituidos y una composicion farmaceutica
ATE541845T1 (de)	2007-08-29	2012-02-15	Schering Corp	2,3-substituierte azaindolderivate zur behandlung von virusinfektionen
JP5416708B2 (ja) *	2007-11-16	2014-02-12	メルク・シャープ・アンド・ドーム・コーポレーション	３−アミノスルホニル置換インドール誘導体およびそれらの使用方法
CN102099351A (zh) *	2007-11-16	2011-06-15	先灵公司	3-杂环取代的吲哚衍生物及其使用方法
CN102159579B (zh) *	2008-06-13	2015-03-25	默沙东公司	三环吲哚衍生物及其使用方法
TW201020245A (en)	2008-08-20	2010-06-01	Schering Corp	Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
CA2734489C (en)	2008-08-20	2016-11-08	Southern Research Institute	Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
US8470834B2 (en)	2008-08-20	2013-06-25	Merck Sharp & Dohme Corp.	AZO-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
US8697694B2 (en)	2008-08-20	2014-04-15	Merck Sharp & Dohme Corp.	Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
EP2435424B1 (en)	2009-05-29	2015-01-21	Merck Sharp & Dohme Corp.	Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
CA2782024A1 (en)	2009-11-25	2011-06-03	Schering Corporation	Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
AU2010341537A1 (en)	2009-12-22	2012-08-09	Merck Sharp & Dohme Corp.	Fused Tricyclic Compounds and methods of use thereof for the treatment of viral diseases
EP2536410B1 (en)	2010-02-18	2015-09-23	Merck Sharp & Dohme Corp.	Substituted pyrimidine derivatives and their use in treating viral infections
JP2013522202A (ja)	2010-03-09	2013-06-13	メルク・シャープ・エンド・ドーム・コーポレイション	縮合三環式シリル化合物およびウイルス疾患の治療のためのその使用方法
CN101824004B (zh) *	2010-04-30	2012-02-22	黄山市歙县宏辉化工有限公司	一种头孢布烯侧链的合成工艺
WO2011139253A2 (en)	2010-05-04	2011-11-10	Mahmut Bilgic	Pharmaceutical compositions comprising ceftibuten
US20140377223A1 (en)	2010-07-26	2014-12-25	Joseph A. Kozlowski	Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
WO2012050848A1 (en)	2010-09-29	2012-04-19	Schering Corporation	Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
EP2697242B1 (en)	2011-04-13	2018-10-03	Merck Sharp & Dohme Corp.	2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
KR20130138840A (ko)	2011-04-13	2013-12-19	머크 샤프 앤드 돔 코포레이션	2''-치환된 뉴클레오시드 유도체 및 바이러스성 질환의 치료를 위한 그의 사용 방법
WO2013033900A1 (en)	2011-09-08	2013-03-14	Merck Sharp & Dohme Corp.	Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
WO2013033901A1 (en)	2011-09-08	2013-03-14	Merck Sharp & Dohme Corp.	Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
WO2013033899A1 (en)	2011-09-08	2013-03-14	Merck Sharp & Dohme Corp.	Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
EP2755981A4 (en)	2011-09-14	2015-03-25	Merck Sharp & Dohme	SILICULAR HETEROCYCLIC DERIVATIVES AND METHOD FOR THEIR USE FOR THE TREATMENT OF VIRUS DISEASES
WO2013109225A1 (en)	2012-01-18	2013-07-25	Mahmut Bilgic	Pharmaceutical tablet formulations comprising ceftibuten
EP2833874A1 (en)	2012-04-04	2015-02-11	Mahmut Bilgic	Capsule formulations comprising ceftibuten
EP2815743A1 (en)	2013-06-21	2014-12-24	Sanovel Ilac Sanayi ve Ticaret A.S.	Ceftibuten formulations
US10167298B2 (en)	2013-10-30	2019-01-01	Merck Sharp & Dohme Corp.	Pseudopolymorphs of an HCV NS5A inhibitor and uses thereof
EP3031450A1 (en)	2014-12-12	2016-06-15	Sanovel Ilac Sanayi ve Ticaret A.S.	Ceftibuten capsule compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB149039A (en) *	1919-04-30	1920-07-30	Lawrence Ennis	Improvements in or relating to steel framed cottages
GB966131A (en) *	1959-04-07	1964-08-06	Union Carbide Corp	Process for the preparation of organic compounds
US3994888A (en) *	1973-06-18	1976-11-30	Eli Lilly And Company	Cephalosporin cleavage process
GB1497039A (en) *	1973-12-05	1978-01-05	Glaxo Lab Ltd	Penicillins and cephalosporins
US4263212A (en) *	1979-02-28	1981-04-21	Rikagaku Kenkyusho	Process for preparation of substituted olefins
GB2076801A (en) *	1980-04-14	1981-12-09	Erba Farmitalia	alpha , beta -Disubstituted Acrylamido Cephalosporins
DE3037997A1 (de) *	1980-10-08	1982-05-13	Bayer Ag	(beta) -lactamantibiotika, verfahren zu deren herstellung sowie sie enthaltende mittel
DE3145727A1 (de) *	1981-11-19	1983-05-26	Bayer Ag, 5090 Leverkusen	Zwischenprodukte, verfahren zu deren herstellung und verfahren zur herstellung von cephalosporinen
CA1201431A (en) *	1981-12-17	1986-03-04	Daiei Tunemoto	.beta.-LACTAM COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND INTERMEDIATE PRODUCTS FOR THE PREPARATION THEREOF
DE3224866A1 (de) *	1982-07-02	1984-01-05	Bayer Ag, 5090 Leverkusen	Ss-lactamantibiotika, verfahren zu deren herstellung sowie sie enthaltende mittel
DE3300593A1 (de) *	1983-01-11	1984-07-12	Bayer Ag, 5090 Leverkusen	Neue cephalosporine und verfahren zu ihrer herstellung
AU575854B2 (en) *	1983-10-04	1988-08-11	Shionogi & Co., Ltd.	7beta-(carboxyalkenamido) cephalosporins

1984
- 1984-09-19 AU AU33300/84A patent/AU575854B2/en not_active Expired
- 1984-09-21 NZ NZ209634A patent/NZ209634A/xx unknown
- 1984-09-21 NZ NZ218741A patent/NZ218741A/xx unknown
- 1984-09-25 PH PH31265A patent/PH20223A/en unknown
- 1984-09-27 CA CA000464215A patent/CA1238910A/en not_active Expired
- 1984-10-01 PT PT79287A patent/PT79287A/pt unknown
- 1984-10-02 NO NO843956A patent/NO173238C/no not_active IP Right Cessation
- 1984-10-02 FI FI843871A patent/FI82057C/fi not_active IP Right Cessation
- 1984-10-03 HU HU843743A patent/HU193298B/hu unknown
- 1984-10-03 GR GR80544A patent/GR80544B/el unknown
- 1984-10-03 IE IE2524/84A patent/IE57744B1/en not_active IP Right Cessation
- 1984-10-03 DK DK474584A patent/DK171043B1/da not_active IP Right Cessation
- 1984-10-03 MX MX013280A patent/MX174328B/es unknown
- 1984-10-03 GB GB08424923A patent/GB2154580B/en not_active Expired
- 1984-10-04 DE DE3486259T patent/DE3486259T2/de not_active Expired - Lifetime
- 1984-10-04 EP EP84111916A patent/EP0136721B1/en not_active Expired - Lifetime
- 1984-10-04 KR KR1019840006134A patent/KR880002376B1/ko not_active IP Right Cessation
- 1984-10-04 IL IL84653A patent/IL84653A/xx not_active IP Right Cessation
- 1984-10-04 IL IL73159A patent/IL73159A/xx not_active IP Right Cessation
- 1984-10-04 AT AT84111916T patent/ATE99311T1/de active
- 1984-10-04 ES ES536502A patent/ES8604602A1/es not_active Expired
- 1984-10-04 DE DE198484111916T patent/DE136721T1/de active Pending
- 1984-10-04 AR AR84298181A patent/AR242392A1/es active
1985
- 1985-03-12 US US06/711,017 patent/US4634697A/en not_active Expired - Lifetime
- 1985-08-29 ES ES547301A patent/ES8605278A1/es not_active Expired
- 1985-08-29 ES ES547300A patent/ES8700222A1/es not_active Expired
- 1985-09-27 NO NO853806A patent/NO176567C/no not_active IP Right Cessation
1986
- 1986-02-20 US US06/831,435 patent/US4748170A/en not_active Expired - Lifetime
- 1986-05-27 PH PH33818A patent/PH21766A/en unknown
1987
- 1987-01-06 GB GB08700123A patent/GB2190914B/en not_active Expired
- 1987-03-04 CA CA000531176A patent/CA1272713A/en not_active Expired - Lifetime
- 1987-11-13 GB GB08726623A patent/GB2198727B/en not_active Expired
- 1987-11-27 IL IL84653A patent/IL84653A0/xx unknown
- 1987-12-09 US US07/132,882 patent/US4912224A/en not_active Expired - Lifetime
1988
- 1988-05-16 AU AU16194/88A patent/AU601842B2/en not_active Expired
- 1988-09-21 KR KR1019880012223A patent/KR880002684B1/ko not_active IP Right Cessation
1994
- 1994-07-04 NL NL940013C patent/NL940013I2/nl unknown

Also Published As

Publication number	Publication date
GB2198727B (en)	1988-11-16
AU601842B2 (en)	1990-09-20
KR850002989A (ko)	1985-05-28
KR880002684B1 (ko)	1988-12-20
GB8726623D0 (en)	1987-12-16
DK474584A (da)	1985-04-05
IL84653A (en)	1990-08-31
ES547301A0 (es)	1986-03-16
FI843871L (fi)	1985-04-05
DE136721T1 (de)	1985-08-29
PT79287A (en)	1984-11-01
NZ218741A (en)	1988-07-28
CA1272713C (no)	1990-08-14
GB2190914A (en)	1987-12-02
ES536502A0 (es)	1986-02-01
KR880002376B1 (ko)	1988-11-03
NO176567B (no)	1995-01-16
NZ209634A (en)	1988-07-28
GR80544B (en)	1985-02-05
NL940013I2 (nl)	1999-06-01
IL84653A0 (en)	1988-04-29
HUT36129A (en)	1985-08-28
EP0136721A2 (en)	1985-04-10
US4748170A (en)	1988-05-31
NO853806L (no)	1985-04-09
ES8605278A1 (es)	1986-03-16
PH21766A (en)	1988-02-18
NO176567C (no)	1995-04-26
GB2154580A (en)	1985-09-11
NO173238B (no)	1993-08-09
MX174328B (es)	1994-05-09
AU1619488A (en)	1988-08-11
GB2190914B (en)	1988-08-17
FI82057B (fi)	1990-09-28
PH20223A (en)	1986-10-23
US4634697A (en)	1987-01-06
NL940013I1 (nl)	1994-08-16
IL73159A (en)	1990-08-31
CA1238910A (en)	1988-07-05
DK171043B1 (da)	1996-04-29
DE3486259D1 (de)	1994-02-10
IE842524L (en)	1985-04-04
ES547300A0 (es)	1986-11-16
AU575854B2 (en)	1988-08-11
CA1272713A (en)	1990-08-14
DK474584D0 (da)	1984-10-03
HU193298B (en)	1987-09-28
FI82057C (fi)	1991-01-10
FI843871A0 (fi)	1984-10-02
AR242392A1 (es)	1993-03-31
DE3486259T2 (de)	1994-07-21
EP0136721A3 (en)	1986-01-22
GB8700123D0 (en)	1987-02-11
IE57744B1 (en)	1993-03-24
GB2198727A (en)	1988-06-22
EP0136721B1 (en)	1993-12-29
US4912224A (en)	1990-03-27
NO173238C (no)	1993-11-17
ES8604602A1 (es)	1986-02-01
GB2154580B (en)	1988-08-17
IL73159A0 (en)	1985-01-31
ES8700222A1 (es)	1986-11-16
GB8424923D0 (en)	1984-11-07
AU3330084A (en)	1985-05-09
ATE99311T1 (de)	1994-01-15

Publication	Publication Date	Title
NO843956L (no)	1985-04-09	Fremgangsmaate for fremstilling av karboksyalkenamido-cefalosporiner
RO90861A (ro)	1987-04-30	Procedeu pentru prepararea etielnglicolului
NO841158L (no)	1984-09-26	Fremgangsmaate for fremstilling av 2-azetidin-4-substituerte forbindelser
NO844710L (no)	1985-05-29	Fremgangsmaate for fremstilling av hoeyrent protein
NO821137L (no)	1982-10-11	Fremgangsmaate for fremstilling av tertiaere alkyletere
NO844388L (no)	1985-06-24	Fremgangsmaate for fremstilling av aminoeteralkoholer
NO851524L (no)	1985-10-18	Fremgangsmaate for fremstilling av fenetanolamin-forbindelser
RO86213A (ro)	1985-03-15	Procedeu pentru prepararea izobutenei
NO844631L (no)	1985-05-28	Fremgangsmaate for fremstilling av tremasse
NO814065L (no)	1982-06-01	Fremgansmaate for fremstilling av imidazolylfenylamidiner
NO845207L (no)	1985-06-24	Fremgangsmaate for fremstilling av diaminopolyalkenyletere
NO170019C (no)	1992-09-02	Fremgangsmaate for fremstilling av deglucoteicoplanin (antibiotikum l 17392)
NO844243L (no)	1985-04-26	Fremgangsmaate for fremstilling av terapeutisk virksomme forbindelser
NO842868L (no)	1985-01-15	Framgangsmaate for framstilling av alkoholer
FI840478A0 (fi)	1984-02-06	Foerfarande foer framstaellning av blodtryckssaenkande n-piperazinylalkanoylanilider
NO823637L (no)	1983-05-04	Fremgangsmaate for fremstilling av eburnamoninderivater
NO169126C (no)	1992-05-13	Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin
NO832830L (no)	1984-02-07	Fremgangsmaate for fremstilling av alfa-arylalkansyrer
NO172547C (no)	1993-08-04	Fremgangsmaate til fremstilling av nalfa-acetyl-eglin b og -c
NO833531L (no)	1984-04-02	Fremgangsmaate for fremstilling av 7-substituerte-3-vinyl-3-cefem-forbindelser
NO830176L (no)	1983-07-29	Fremgangsmaate for fremstilling av ultrarent toriumfluorid
NO163061C (no)	1990-03-28	Fremgangsmaate til fremstilling av ferromangan.
NO830309L (no)	1984-08-01	Fremgangsmaate for fremstilling av tennsats for varmeanordning
NO845006L (no)	1985-06-17	Fremgangsmaate for fremstilling av antibiotikum l 17054
NO831874L (no)	1983-11-28	Fremgangsmaate for fremstilling av trifenylbuten-derivater

Legal Events

Date	Code	Title	Description
2004-12-13	MM1K	Lapsed by not paying the annual fees